SCHEMBL3058780

SCHEMBL3058780

CC(C)(C)OC(=O)N(Cc1ccc(NC2CC2)cc1)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.44
CHRM3 P20309 2/20 0.44
CHRM2 P08172 1/20 0.44
KDM1A O60341 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KCNQ4 P56696 3/20 0.41
KCNQ5 Q9NR82 3/20 0.41
PTPRB P23467 1/20 0.41
PTPN11 Q06124 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MLNR O43193 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPK1 P28482 2/20 0.39
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3058213 0.87 CHRM1 (0.44) CHRM1CHRM3CHRM2KCNQ4KCNQ5
SCHEMBL4738206 0.83 CHRM2 (0.46) CHRM1CHRM3CHRM2ALDH1A1MLNR
SCHEMBL3049232 0.81 CHRM1 (0.43) CHRM1CHRM3CHRM2KDM1AHDAC8
SCHEMBL18721166 0.80 KCNQ4 (0.43) CHRM1CHRM3CHRM2KDM1AHDAC8
SCHEMBL3063916 0.80 KCNQ4 (0.43) CHRM1CHRM3CHRM2KDM1AHDAC8
SCHEMBL18721167 0.76 NR1D1 (0.47) ALDH1A1CYP3A4NPC1MAPTRAB9A
SCHEMBL31205987 0.74 KDM1A (0.49) KDM1AALDH1A1MAPK1HTTNPC1
SCHEMBL2527066 0.74 MCHR1 (0.45) KDM1AHDAC8HDAC6KCNQ4KCNQ5
SCHEMBL3065683 0.73 BCL2A1 (0.42) KDM1AHDAC8HDAC6KCNQ4KCNQ5
SCHEMBL16640701 0.73 NR1H4 (0.38) BCL2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US disclosed
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US disclosed
EP-2099754-A1 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2009-09-16 EP disclosed
EP-2097379-A1 CARBOXAMIDE DERIVATIVES AS ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2009-09-09 EP disclosed
EP-2091917-A1 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2009-08-26 EP disclosed
WO-2008073936-A1 CARBOXAMIDE DERIVATIVES AS ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073936-A1 CARBOXAMIDE DERIVATIVES AS ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073929-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073929-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073934-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073461-A2 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073934-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed
WO-2008073461-A2 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267697-A1 ION CHANNEL MODULATORS CACNA1E, CACNA1A, CACNA1S CHRM1 215/4885CHRM3 217/4885CHRM2 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.